An Open-Label Pilot Study for Atomoxetine in Adult Subjects With Attention Deficit/Hyperactivity Disorder.
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2011
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 03 May 2008 Status changed from in progress to completed.
- 08 Mar 2008 Status changed from recruiting to in progress.